• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Nat Turner on Flatiron Health's Emphasis on Community Oncologists

Video

Flatiron Health focuses on helping community oncologists because they still care for the majority of patients with cancer and make it possible for patients to get care without traveling long distances, explained Nat Turner, co-founder and CEO of Flatiron Health.

Flatiron Health focuses on helping community oncologists because they still care for the majority of patients with cancer and make it possible for patients to get care without traveling long distances, explained Nat Turner, co-founder and CEO of Flatiron Health.

Transcript (slightly modified)

Why does Flatiron Health largely focus on community oncologists?

Community oncology, for us, is critical because that’s where most of the patients are treated with cancer, so somewhere probably around 60% today—used to be 85%, but it’s probably going back to 85%—of cancer patients that are treated in community. Also, patients are generally elderly with cancer, meaning it’s harder to travel, they need to be closer to caregivers and the only true scalable solution is a close-to-home option, which community oncology can provide.

It’s not very scalable to have a hospital in every single small town in America, you really need a more distributed network and we also think it’s the best way to take care of patients, to build closer relationships with the patients, the physicians do the care teams, it’s a lot less complicated of an environment to navigate as a patient, and it’s just a lot more kind of closer touch.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.